These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3277636)

  • 1. Can anticancer therapy be improved by sequential use of cytotoxic and cytostatic (differentiating or immunomodulating) agents to suppress tumor cell phenotypic diversification?
    Lotan R; Nicolson GL
    Biochem Pharmacol; 1988 Jan; 37(2):149-54. PubMed ID: 3277636
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical hyperthermia combined with drugs and radiation. A phase I/II study.
    Dahl O; Mella O; Mehus A; Liavaag PG
    Strahlenther Onkol; 1987 Jul; 163(7):446-8. PubMed ID: 3616903
    [No Abstract]   [Full Text] [Related]  

  • 4. Supralethal dose therapy for sensitive cancers.
    Kaizer H
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):151-2. PubMed ID: 6363094
    [No Abstract]   [Full Text] [Related]  

  • 5. A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.
    Robertson-Tessi M; El-Kareh A; Goriely A
    J Theor Biol; 2015 Sep; 380():569-84. PubMed ID: 26087282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.
    Wu J; Waxman DJ
    Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies on the combined immunochemotherapy with a streptococcal preparation (Picibanil) and other anticancer drugs.
    Misawa S; Sawai K; Takino T; Masuda M; Abe T; Kawai K
    Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):291-305. PubMed ID: 479655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytotoxic Agents and Immune Checkpoint Inhibitors].
    Kawazoe A; Shitara K
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):717-721. PubMed ID: 28912395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose intensity in anticancer chemotherapy. Paris, 19 December 1994].
    Droz JP; Maraninchi D
    Bull Cancer; 1995; 82 Suppl 1():1s-2s. PubMed ID: 7626848
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant cytostatic therapy].
    Einhorn J; Larsson LG
    Lakartidningen; 1978 Feb; 75(5):309-12. PubMed ID: 633992
    [No Abstract]   [Full Text] [Related]  

  • 11. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
    Emens LA; Middleton G
    Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell cycle and its significance for cancer treatment.
    Hill BT; Baserga R
    Cancer Treat Rev; 1975 Sep; 2(3):159-75. PubMed ID: 1104161
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapy.
    Mathé G; Reizenstein P; Eriguchi M
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():75-92. PubMed ID: 3074229
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop.
    Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R
    Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventing diversification of malignant tumor cells during therapy.
    Nicolson GL; Lotan R
    Clin Exp Metastasis; 1986; 4(4):231-5. PubMed ID: 3791725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of small cell bronchial carcinoma].
    Rainer H
    Onkologie; 1984 Oct; 7(5):276-84. PubMed ID: 6096782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The problems of combining chemotherapy and radiotherapy].
    Tanaka Y; Hasegawa T; Akagi K; Kato T
    Gan No Rinsho; 1987 Oct; 33(13):1664-72. PubMed ID: 3694800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoughts on cancer chemotherapy and combination modality therapy (1974).
    Skipper HE
    JAMA; 1974 Nov; 230(7):1033-5. PubMed ID: 4608173
    [No Abstract]   [Full Text] [Related]  

  • 19. Applicability of phase I trial results in the design of phase II and III biological response modifier trials.
    Pinsky CM
    Cancer Treat Rep; 1985 Oct; 69(10):1171-3. PubMed ID: 4042095
    [No Abstract]   [Full Text] [Related]  

  • 20. Rethinking AIDS and cancer.
    Shearer GM; Clerici M
    Science; 1996 Oct; 274(5285):163-4. PubMed ID: 8927973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.